China Pharma (NYSE:CPHI) Stock Falls 2.9% – Time to Sell?

by · The Markets Daily

China Pharma Holdings, Inc. (NYSE:CPHI – Get Free Report)’s share price fell 2.9% during trading on Thursday. The company traded as low as $0.6647 and last traded at $0.6767. 123,288 shares were traded during trading, a decline of 94% from the average daily volume of 1,974,334 shares. The stock had previously closed at $0.6970.

China Pharma Stock Down 2.7%

The business has a fifty day moving average of $0.80 and a 200 day moving average of $0.87. The firm has a market cap of $28.33 million, a P/E ratio of -1.53 and a beta of 1.04. The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22.

About China Pharma

(Get Free Report)

China Pharma Holdings, Inc is a pharmaceutical company based in Harbin, China. Through its operating subsidiaries, the company develops, manufactures and markets pharmaceutical products for the Chinese healthcare market.

Its product portfolio has included prescription medicines, over-the-counter drugs, antibiotics, cardiovascular treatments, biopharmaceutical products and traditional Chinese medicines. The company has also offered pharmaceutical products used in hospitals and other healthcare settings, as well as certain nutritional and health-related products.

China Pharma primarily serves customers in China through pharmaceutical distribution channels and healthcare institutions.

Read More